The Administration of Lemborexant at Admission is Not Associated with Inpatient Falls: A Multicenter Retrospective Observational Study
Risa Hirata,Naoko E Katsuki,Hitomi Shimada,Eiji Nakatani,Kiyoshi Shikino,Chihiro Saito,Kaori Amari,Yoshimasa Oda,Midori Tokushima,Masaki Tago
DOI: https://doi.org/10.2147/ijgm.s452278
IF: 2.145
2024-03-26
International Journal of General Medicine
Abstract:Risa Hirata, 1 Naoko E Katsuki, 1 Hitomi Shimada, 2 Eiji Nakatani, 3 Kiyoshi Shikino, 4, 5 Chihiro Saito, 6 Kaori Amari, 7 Yoshimasa Oda, 8 Midori Tokushima, 1 Masaki Tago 1 1 Department of General Medicine, Saga University Hospital, Saga, Japan; 2 Shimada Hospital of Medical Corporation Chouseikai, Saga, Japan; 3 Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan; 4 Department of General Medicine, Chiba University Hospital, Chiba, Japan; 5 Department of Community-Oriented Medical Education, Chiba University Graduate School of Medicine, Chiba, Japan; 6 Shizuoka General Hospital, Shizuoka, Japan; 7 Department of Emergency Medicine, Saga-Ken Medical Centre Koseikan, Saga, Japan; 8 Department of General Medicine, Yuai-Kai Foundation and Oda Hospital, Saga, Japan Correspondence: Masaki Tago, Department of General Medicine, Saga University Hospital, 5-1-1 Nabeshima, Saga, 849-8501, Japan, Tel +81 952 34 3238, Fax +81 952 34 2029, Email Purpose: There has been no large-scale investigation into the association between the use of lemborexant, suvorexant, and ramelteon and falls in a large population. This study, serving as a pilot investigation, was aimed at examining the relationship between inpatient falls and various prescribed hypnotic medications at admission. Patients and Methods: This study was a sub-analysis of a multicenter retrospective observational study conducted over a period of 3 years. The target population comprised patients aged 20 years or above admitted to eight hospitals, including chronic care, acute care, and tertiary hospitals. We extracted data on the types of hypnotic medications prescribed at admission, including lemborexant, suvorexant, ramelteon, benzodiazepines, Z-drugs, and other hypnotics; the occurrence of inpatient falls during the hospital stay; and patients' background information. To determine the outcome of inpatient falls, items with low collinearity were selected and included as covariates in a forced-entry binary logistic regression analysis. Results: Overall, 150,278 patients were included in the analysis, among whom 3,458 experienced falls. The median age of the entire cohort was 70 years, with men constituting 53.1%. Binary logistic regression analysis revealed that the prescription of lemborexant, suvorexant, and ramelteon at admission was not significantly associated with inpatient falls. Conclusion: The administration of lemborexant, suvorexant, and ramelteon at admission may not be associated with inpatient falls. Keywords: lemborexant, hypnotics, in-hospital falls, risk factor In-hospital falls present significant challenges, contributing to societal burdens such as increased healthcare costs and physical and psychological burdens on patients, 1 including physical sequelae and fear of falls. 2,3 Hypnotic medications are recognized risk factors for falls, 4 and their use often increases during hospitalization because of changes in both the environment and the patient's condition, leading to insomnia. 5 While benzodiazepine hypnotics (BZs) have been previously reported to be associated with falls, 6 in recent years, new hypnotic medications, such as lemborexant, suvorexant, and ramelteon, have become available. However, there is a dearth of multicenter studies examining the association between these novel hypnotic medications and falls. Definitive evidence of the association between suvorexant and falls has not been shown, even in studies with small populations. 7,8 Remarkably, the relationship between lemborexant and falls has been scarcely investigated, with only few single-center studies addressing this issue. 9 This study, serving as a pilot investigation, was aimed at examining the association between inpatient falls and various hypnotic medications by using multicenter data. This study was a sub-analysis of an unpublished multicenter retrospective study conducted from April 1, 2018, to March 31, 2021, targeting patients aged 20 years or above admitted to eight hospitals, including chronic care, acute care, and tertiary hospitals. Patient data, including background information such as age, 10,11 sex, underlying conditions, and the occurrence of inpatient falls, were extracted from their medical records. We collected prescription data from drug pharmacy records for medications with the first three digits of the Ministry of Health, Labour and Welfare Drug Code (YJ Code) 112, suvorexant, lemborexant, and ramelteon, up to the day following admission. Subsequently, we cate -Abstract Truncated-
medicine, general & internal